Group 1 - The core viewpoint of the news is that Haocen Medical's stock has seen a recent increase, but the company is facing significant financial challenges as indicated by its latest quarterly report [1] - As of the first quarter of 2025, Haocen Medical reported a revenue of 143 million yuan, which represents a year-on-year decrease of 12.58% [1] - The net profit for the same period was a loss of approximately 12.21 million yuan, reflecting a year-on-year decline of 167.13% [1] Group 2 - Haocen Medical's latest closing price was 2.62 yuan, with a market capitalization of 2.201 billion yuan and a price-to-book ratio of 5.76, marking a new low in the past 20 days [1] - The company is primarily engaged in oral medical services and the research, production, and sales of permanent magnetic switches and high/low voltage switchgear products [1] - The company has five institutional investors holding a total of 256.83 million shares, with a combined market value of 709 million yuan [1] Group 3 - In comparison to industry averages, Haocen Medical's price-to-earnings ratio (TTM) is -48.55, while the industry average is 38.66 [2] - The company's price-to-book ratio of 5.76 is higher than the industry median of 2.725 [2] - Other companies in the industry, such as Run Da Medical and He Shi Eye Hospital, show significantly higher price-to-earnings ratios, indicating a challenging competitive landscape for Haocen Medical [2]

Company Overview - Haocen Medical closed at 2.41 yuan, down 5.49%, with a latest price-to-book ratio of 5.30 and a total market capitalization of 2.024 billion yuan [1] - As of the first quarter of 2025, five institutions held shares in Haocen Medical, with a total holding of 256.8293 million shares valued at 709 million yuan [1] Business Operations - Haocen Medical primarily engages in oral medical services and the research, production, and sales of permanent magnet switches and high/low voltage switchgear products [1] - The main products include medical oral services, industrial switch products, and credit big data software services [1] Financial Performance - For the first quarter of 2025, the company reported operating revenue of 143 million yuan, a year-on-year decrease of 12.58% [1] - The net profit for the same period was -12,214,580.55 yuan, reflecting a year-on-year decline of 167.13% [1] - The sales gross margin stood at 38.50% [1] Industry Comparison - Haocen Medical's PE (TTM) is -44.66, while the industry average is 40.74 [2] - The company's market capitalization is 2.024 billion yuan, compared to the industry median of 51.49 billion yuan [2]

Core Insights - Haocen Medical's stock closed at 2.61 yuan, up 3.16%, with a latest price-to-book ratio of 4.90 and a total market capitalization of 2.192 billion yuan [1] - As of September 30, 2024, Haocen Medical had 44,932 shareholders, an increase of 3,565 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The company primarily engages in oral medical services and the research, production, and sales of permanent magnet switches and high/low voltage switchgear products, with key offerings including medical oral services, industrial switch products, and credit big data software services [1] Financial Performance - For the third quarter of 2024, Haocen Medical reported operating revenue of 635 million yuan, a year-on-year increase of 21.27%, and a net profit of 13.4967 million yuan, reflecting a year-on-year decrease of 17.31%, with a gross profit margin of 47.97% [1] - The company's price-to-earnings (P/E) ratio (TTM) is -22.56, while the industry average is 46.79, indicating a significant divergence from industry norms [2] - The total market capitalization of Haocen Medical is 2.192 billion yuan, compared to the industry median of 4.888 billion yuan [2]

Group 1 - The core viewpoint of the news is that Haocen Medical's stock has experienced a decline, with a closing price of 2.82 yuan and a market capitalization of 2.369 billion yuan, indicating a challenging market environment for the company [1] - On March 28, Haocen Medical saw a net inflow of 187,600 yuan in main funds, but over the past five days, there was a total outflow of 4.5704 million yuan, suggesting a negative trend in investor sentiment [1] - The company primarily engages in oral medical services and the research, production, and sales of permanent magnet switches and high/low voltage switchgear products, with key offerings including medical oral services, industrial switch products, and credit big data software services [1] Group 2 - For the latest financial performance, Haocen Medical reported a revenue of 635 million yuan for the third quarter of 2024, reflecting a year-on-year increase of 21.27%, while the net profit was 13.4967 million yuan, showing a year-on-year decrease of 17.31%, with a gross profit margin of 47.97% [1] - The company's price-to-earnings (PE) ratio (TTM) is -24.37, and the price-to-book (PB) ratio is 5.29, with a total market value of 2.369 billion yuan, which is significantly lower than the industry average PE of 48.41 and PB of 3.76 [2] - The industry median PE is 43.56 and median PB is 2.84, indicating that Haocen Medical is underperforming compared to its peers in the healthcare sector [2]

股东方面，截至2024年9月30日，皓宸医疗股东户数44932户，较上次增加3565户，户均持股市值35.28 万元，户均持股数量2.76万股。 皓宸医疗科技股份有限公司主要从事口腔医疗服务以及永磁开关及高低压开关成套设备产品的研发、生 产和销售。其主要产品有医疗口腔服务、实业开关产品、征信大数据软件服务。 皓宸医疗收盘下跌1.04%，最新市净率5.35，总市值 23.94亿元 3月25日，皓宸医疗今日收盘2.85元，下跌1.04%，最新市净率5.35，总市值23.94亿元。 最新一期业绩显示，2024年三季报，公司实现营业收入6.35亿元，同比21.27%；净利润1349.67万元， 同比-17.31%，销售毛利率47.97%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)10皓宸医疗-24.63-25.375.3523.94亿行业平均 44.4036.383.76164.34亿行业中值42.8133.422.9348.88亿1昭衍新药-17093.5039.311.95156.04亿2普瑞眼 科-196.3624.542.9665.76亿3何氏眼科-164.0050.281.6531.95亿4迪 ...